C. Frank Bennett
for the development of an effective antisense oligonucleotide therapy for children with the neurodegenerative disease spinal muscular atrophy.
Affiliated at time of winning
Carlsbad, United States
Recognition for work with lasting impact
for the development of an effective antisense oligonucleotide therapy for children with the neurodegenerative disease spinal muscular atrophy.
Carlsbad, United States